Status:

COMPLETED

Choices About Genetic Testing And Learning Your Risk With Smart Technology

Lead Sponsor:

Rutgers, The State University of New Jersey

Conditions:

Ovarian Cancer

Fallopian Tube Cancer

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study seeks to enhance genetic education and increase the uptake of genetic testing for hereditary cancer risk among cancer survivors. The study will focus on the feasibility and acceptability of...

Detailed Description

Research Design and Methods: This study encompasses refinement of the digital intervention prototype through usability and user interface testing, and subsequent pilot/feasibility testing of a multi-...

Eligibility Criteria

Inclusion

  • User/Usability Testing
  • Age 18 or older
  • Diagnosed with ovarian, fallopian tube, peritoneal, breast, pancreatic, colorectal, endometrial or prostate cancer
  • Speak/read and understand English
  • Capable of providing informed consent
  • Have Internet access (via smartphone, tablet, or computer)
  • Randomized Feasibility Trial
  • Age 18 or older
  • Diagnosed with ovarian, fallopian tube, peritoneal, breast, pancreatic, colorectal, endometrial or prostate cancer
  • Meet National Comprehensive Cancer Network (NCCN) criteria for germline GT
  • Speak/read and understand English
  • Capable of providing informed consent
  • Have Internet access (via smartphone, tablet or computer)

Exclusion

  • Participants will be 18 years of age or older because germline genetic testing is generally not recommended in children when the test results would not impact clinical management. Participants from the user and usability testing phases are not eligible for the feasibility trial. Feasibility trial participants cannot have previously undergone germline GT for hereditary cancer risk.

Key Trial Info

Start Date :

September 26 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 26 2025

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT06184867

Start Date

September 26 2023

End Date

June 26 2025

Last Update

December 3 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Rutgers University

New Brunswick, New Jersey, United States, 08901